Literature DB >> 23950578

Hippocampus, hippocampal sclerosis and epilepsy.

Krzysztof Sendrowski1, Wojciech Sobaniec.   

Abstract

Hippocampal sclerosis (HS) is considered one of the major pathogenic factors of drug-resistant temporal lobe epilepsy. HS is characterized by selective loss of pyramidal neurons - especially of sectors CA1 and CA3 of the hippocampus - pathological proliferation of interneuron networks, and severe glia reaction. These changes occur in the course of long-term and complex epileptogenesis. The authors, on the basis of a review of the literature and own experience, present the pathomechanisms leading to hippocampal sclerosis and epileptogenesis, including various morphological and functional elements of this structure of the brain and pharmacological possibilities of preventing these processes.

Entities:  

Mesh:

Year:  2013        PMID: 23950578     DOI: 10.1016/s1734-1140(13)71033-8

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  21 in total

1.  Expression and localization of type II diacylglycerol kinase isozymes δ and η in the developing mouse brain.

Authors:  Takako Usuki; Hiromichi Sakai; Takao Shionoya; Naruki Sato; Fumio Sakane
Journal:  J Histochem Cytochem       Date:  2014-10-31       Impact factor: 2.479

2.  Effect of Liraglutide on Corneal Kindling Epilepsy Induced Depression and Cognitive Impairment in Mice.

Authors:  Prashant Koshal; Puneet Kumar
Journal:  Neurochem Res       Date:  2016-03-26       Impact factor: 3.996

3.  Altered microstructure in temporal lobe epilepsy: a diffusional kurtosis imaging study.

Authors:  L Bonilha; C-Y Lee; J H Jensen; A Tabesh; M V Spampinato; J C Edwards; J Breedlove; J A Helpern
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-11       Impact factor: 3.825

4.  Altered S100 Calcium-Binding Protein B and Matrix Metallopeptidase 9 as Biomarkers of Mesial Temporal Lobe Epilepsy with Hippocampus Sclerosis.

Authors:  Nagwa A Meguid; Hatem Samir; Geir Bjørklund; Mona Anwar; Adel Hashish; Farouk Koura; Salvatore Chirumbolo; Saher Hashem; Mona A El-Bana; Hebatalla S Hashem
Journal:  J Mol Neurosci       Date:  2018-10-20       Impact factor: 3.444

5.  Leukocyte Infiltration Triggers Seizure Recurrence in a Rat Model of Temporal Lobe Epilepsy.

Authors:  Zanhua Liu; Suping Wang; Jinjie Liu; Feng Wang; Yi Liu; Yongbo Zhao
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

6.  Peroxisome proliferator-activated receptor-γ agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus.

Authors:  Yong-Zhi San; Yu Liu; Yu Zhang; Ping-Ping Shi; Yu-Lan Zhu
Journal:  Mol Med Rep       Date:  2015-04-17       Impact factor: 2.952

7.  The Peptide Network between Tetanus Toxin and Human Proteins Associated with Epilepsy.

Authors:  Guglielmo Lucchese; Jean Pierre Spinosa; Darja Kanduc
Journal:  Epilepsy Res Treat       Date:  2014-06-01

8.  Caspase 3 involves in neuroplasticity, microglial activation and neurogenesis in the mice hippocampus after intracerebral injection of kainic acid.

Authors:  Tsai-Teng Tzeng; Huey-Jen Tsay; Luping Chang; Chia-Lin Hsu; Tzu-Hsuan Lai; Fong-Lee Huang; Young-Ji Shiao
Journal:  J Biomed Sci       Date:  2013-12-06       Impact factor: 8.410

9.  Hsp60 response in experimental and human temporal lobe epilepsy.

Authors:  Antonella Marino Gammazza; Roberto Colangeli; Gergely Orban; Massimo Pierucci; Giancarlo Di Gennaro; Margherita Lo Bello; Alfredo D'Aniello; Fabio Bucchieri; Cristoforo Pomara; Mario Valentino; Richard Muscat; Arcangelo Benigno; Giovanni Zummo; Everly Conway de Macario; Francesco Cappello; Giuseppe Di Giovanni; Alberto J L Macario
Journal:  Sci Rep       Date:  2015-03-24       Impact factor: 4.379

10.  Astrocytic Acid-Sensing Ion Channel 1a Contributes to the Development of Chronic Epileptogenesis.

Authors:  Feng Yang; Xiaolong Sun; Yinxiu Ding; Hui Ma; Tangpeng Ou Yang; Yue Ma; Dong Wei; Wen Li; Tianle Xu; Wen Jiang
Journal:  Sci Rep       Date:  2016-08-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.